- Home
- UTG vs TWST Comparison
UTG vs TWST Comparison
Compare UTG & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UTG
- TWST
- Stock Information
- Founded
- UTG 2003
- TWST 2013
- Country
- UTG United States
- TWST United States
- Employees
- UTG N/A
- TWST N/A
- Industry
- UTG Investment Managers
- TWST Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- UTG Finance
- TWST Health Care
- Exchange
- UTG Nasdaq
- TWST Nasdaq
- Market Cap
- UTG 2.8B
- TWST 3.1B
- IPO Year
- UTG N/A
- TWST 2018
- Fundamental
- Price
- UTG $33.72
- TWST $41.31
- Analyst Decision
- UTG
- TWST Buy
- Analyst Count
- UTG 0
- TWST 10
- Target Price
- UTG N/A
- TWST $52.50
- AVG Volume (30 Days)
- UTG 319.3K
- TWST 933.0K
- Earning Date
- UTG 01-01-0001
- TWST 02-03-2025
- Dividend Yield
- UTG 9.31%
- TWST N/A
- EPS Growth
- UTG N/A
- TWST N/A
- EPS
- UTG N/A
- TWST N/A
- Revenue
- UTG N/A
- TWST $330,189,000.00
- Revenue This Year
- UTG N/A
- TWST $22.59
- Revenue Next Year
- UTG N/A
- TWST $17.62
- P/E Ratio
- UTG N/A
- TWST N/A
- Revenue Growth
- UTG N/A
- TWST 25.85
- 52 Week Low
- UTG $23.24
- TWST $27.41
- 52 Week High
- UTG $29.50
- TWST $60.90
- Technical
- Relative Strength Index (RSI)
- UTG 52.54
- TWST 33.83
- Support Level
- UTG $33.95
- TWST $43.93
- Resistance Level
- UTG $34.40
- TWST $48.58
- Average True Range (ATR)
- UTG 0.43
- TWST 3.60
- MACD
- UTG 0.01
- TWST -0.96
- Stochastic Oscillator
- UTG 67.46
- TWST 2.96
About UTG Reaves Utility Income Fund of Beneficial Interest
Reaves Utility Income Fund is a closed-end management investment company. The company's investment objective is to provide a high level of after-tax income and total return consisting of tax-advantaged dividend income and capital appreciation. It invests a portion of its total assets in securities of utility companies, which may include companies in the electric, gas, water, telecommunications sectors, as well as other companies engaged in other infrastructure operations.
About TWST Twist Bioscience Corporation
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.